CYPRESS GROVE BEHAVIORAL HEALTH — History
CCN 194083 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$9M
Latest Revenue (FY2022)
+55.3%
Revenue CAGR (3yr)
-1.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $4M | $8M | $9M | +10.8% | +55.3% |
| Operating Expenses | $3M | $8M | $9M | +15.8% | +59.9% |
| Operating Margin | 4.7% | 3.3% | -1.0% | -128.9% | +0.0% |
| Net Income | $0M | $0M | $-0M | -132.0% | +0.0% |
| Licensed Beds | 60 | 60 | 60 | +0.0% | +0.0% |
| Total Patient Days | 5,394 | 12,222 | 12,001 | -1.8% | +49.2% |
| Medicare Day % | nan% | nan% | nan% | +nan% | +nan% |
| Medicaid Day % | 5% | 4% | 5% | +22.8% | -4.2% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +141.1% ($4M → $9M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▶ Stable
vs State Average ()
Revenue Growth
+55.3%
This Hospital
+7.6%
State Avg
Latest Margin
-1.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $11M | -3.8% |
| FY2024 (proj) | $14M | -6.7% |
| FY2025 (proj) | $16M | -9.5% |